SHR-1707 is a humanized anti-Abeta IgG1 monoclonal antibody. SHR-1707 binds Abeta fibrils and monomers, blocking plaque formation and promoting the microglial phagocytosis of Abeta. SHR-1707 reduces brain Abeta deposition in 5xFAD transgenic mice. SHR-1707 can be used for Alzheimers disease research. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
